Financial Performance - Quanterix Corporation reported a quarterly loss of 0.53pershare,betterthantheZacksConsensusEstimateofalossof0.69, but worse than a loss of 0.26pershareayearago,indicatinganearningssurpriseof23.1930.33 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 8.99%, although this is a decline from year-ago revenues of 32.07million[2]−Overthelastfourquarters,Quanterixhassurpassedconsensusrevenueestimatesthreetimes[2]StockPerformance−Quanterixshareshavedeclinedapproximately50.30.38 on revenues of 30.83million,andforthecurrentfiscalyear,itis−1.62 on revenues of $138.32 million [7] Industry Outlook - The Medical - Products industry, to which Quanterix belongs, is currently ranked in the bottom 33% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Quanterix's stock performance [5]